AGTXOTCBiological Products, (No Diagnostic Substances)Fiscal year ends March 31
Agentix Corp.
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$0.02+0.00 (0.00%)
Close on Oct 16, 2026
- Market cap
- $801.34K
- P/E (TTM)
- –
- Dividend yield
- –
Community
Notes and questions about Agentix from other investors
No posts about AGTX yet
Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.